Effects of 3-O-methyl on L-dopa-facilitated synthesis and efflux of dopamine from rat striatal slices
- PMID: 8590982
- PMCID: PMC1909121
- DOI: 10.1111/j.1476-5381.1995.tb17219.x
Effects of 3-O-methyl on L-dopa-facilitated synthesis and efflux of dopamine from rat striatal slices
Abstract
1. The effect of L-dopa on the spontaneous and KCl-evoked efflux of dopamine from rat striatal slices, measured by high performance liquid chromatography (h.p.l.c.) with electrochemical detection (e.c.d.) was investigated in the absence and presence of 3-O-methyl dopa (OMD), an O-methylated metabolite of L-dopa. 2. The addition of exogenous L-dopa (10 microM) significantly increased both the spontaneous efflux of dopamine and that evoked by KCl. 3. In the presence of 50 microM OMD, the effects of L-dopa on the spontaneous and KCl-evoked efflux of dopamine were smaller but only the former was significantly different from that in the absence of OMD. However, the total efflux of dopamine during the overall superfusion time (70 min) including KCl depolarization was significantly lower than in the absence of OMD. 4. Analysis of tissue content after superfusion revealed that the levels of dopa and dopamine in slices superfused with L-dopa in the presence of OMD were significantly higher than those superfused with L-dopa alone. 5. The finding that OMD significantly reduced the efflux of dopamine whilst increasing its concentration in striatal slices after L-dopa superfusion could explain the reduced efficacy seen after long-term therapy with L-dopa and a peripheral dopa decarboxylase inhibitor in Parkinsonian patients when plasma and brain OMD are very high.
Similar articles
-
Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.Synapse. 1999 Oct;34(1):36-46. doi: 10.1002/(SICI)1098-2396(199910)34:1<36::AID-SYN5>3.0.CO;2-G. Synapse. 1999. PMID: 10459170
-
3-O-methyldopa blocks dopa metabolism in rat corpus striatum.Ann Neurol. 1982 Sep;12(3):267-71. doi: 10.1002/ana.410120310. Ann Neurol. 1982. PMID: 7137962
-
The effects of L-dopa on in vitro dopamine release from striatum.Brain Res. 1990 Feb 5;508(2):181-7. doi: 10.1016/0006-8993(90)90394-q. Brain Res. 1990. PMID: 2106362
-
The effect of reserpine treatment in vivo upon L-dopa and amphetamine evoked dopamine and DOPAC efflux in vitro from the corpus striatum of male rats.J Neural Transm Gen Sect. 1994;95(3):209-22. doi: 10.1007/BF01271567. J Neural Transm Gen Sect. 1994. PMID: 7865176
-
Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.J Pharmacol Exp Ther. 1993 Nov;267(2):912-8. J Pharmacol Exp Ther. 1993. PMID: 8246167
Cited by
-
The role of 3-O-methyldopa in the side effects of L-dopa.Neurochem Res. 2008 Mar;33(3):401-11. doi: 10.1007/s11064-007-9442-6. Epub 2007 Aug 24. Neurochem Res. 2008. PMID: 17713853
-
3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of L-DOPA.BMC Neurosci. 2016 Jul 25;17(1):52. doi: 10.1186/s12868-016-0289-0. BMC Neurosci. 2016. PMID: 27456338 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources